| Entry |
|
|---|
| Name |
|
|---|
| Formula |
C5H5N5S
|
|---|
| Exact mass |
167.0266
|
|---|
| Mol weight |
167.1917
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00983 | Drug metabolism - other enzymes |
|
|---|
| Enzyme |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BB Purine analogues
L01BB03 Tioguanine
D08603 Tioguanine (INN)
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG00684 Tioguanine
D08603 Tioguanine
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Pentosyltransferases
HPRT1
D08603 Tioguanine (INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 11
1 C8y C 24.9532 -17.2107
2 C8y C 24.8889 -15.8068
3 N5x N 26.0940 -17.9067
4 N4x N 23.5553 -17.6376
5 C8y C 26.0940 -15.1107
6 N5x N 23.5553 -15.3739
7 C8y C 27.3106 -17.2107
8 C8x C 22.7306 -16.5087
9 N5x N 27.3106 -15.8068
10 S1a S 26.0998 -13.7068
11 N1a N 28.5274 -17.9009
BOND 12
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 2
7 4 8 1
8 5 9 2
9 5 10 1
10 7 11 1
11 6 8 2
12 7 9 1
|
|---|
